Tarsus Pharmaceuticals (TARS) Debt Ratio (2022 - 2026)

Tarsus Pharmaceuticals' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.12 for Q1 2026.

• In Q1 2026, Debt Ratio fell 13.1% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (down 13.1% YoY), while the FY2025 annual figure was 0.13, down 32.39% from the prior year.
• Debt Ratio was 0.12 for Q1 2026 at Tarsus Pharmaceuticals, down from 0.13 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.19 in Q4 2024 to a low of 0.08 in Q2 2022.
• Historically, Debt Ratio has averaged 0.13 across 5 years, with a median of 0.12 in 2026.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio surged 72.12% in 2024, then tumbled 32.39% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.09 in 2022, then surged by 31.69% to 0.11 in 2023, then soared by 69.68% to 0.19 in 2024, then sank by 32.39% to 0.13 in 2025, then retreated by 3.05% to 0.12 in 2026.
• The last three Debt Ratio figures came in at 0.12 (Q1 2026), 0.13 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.